Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADMA Biologics Inc - Common Stock
(NQ:
ADMA
)
7.920
-0.230 (-2.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,545,902
Open
8.150
Bid (Size)
7.920 (200)
Ask (Size)
8.010 (800)
Prev. Close
8.150
Today's Range
7.875 - 8.275
52wk Range
7.210 - 22.37
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
May 26, 2026
From
Pomerantz LLP
Via
GlobeNewswire
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 26, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Performance
YTD
-55.7%
-55.7%
1 Month
-27.5%
-27.5%
3 Month
-49.0%
-49.0%
6 Month
-58.8%
-58.8%
1 Year
-60.2%
-60.2%
More News
Read More
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 22, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 22, 2026
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
ADMA Biologics (NASDAQ:ADMA) Shares Plunge on Q1 Miss and Revenue Guidance Cut
↗
May 06, 2026
Via
Chartmill
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
↗
May 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
Regulatory Compliance
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year
↗
May 21, 2026
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
May 19, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 08, 2026
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
ADMA (ADMA) Q1 2026 Earnings Transcript
↗
May 06, 2026
Via
The Motley Fool
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 06, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
What's going on in today's after hours session
↗
May 06, 2026
Via
Chartmill
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
May 06, 2026
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
May 04, 2026
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 03, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
April 29, 2026
From
ADMA Biologics, Inc.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
April 28, 2026
From
Pomerantz LLP
Via
GlobeNewswire
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
April 24, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
April 21, 2026
From
Pomerantz LLP
Via
GlobeNewswire
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
April 21, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Securities Fraud Investigation Into ADMA Biologics, Inc. (ADMA) Continues – Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
April 20, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
April 20, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into ADMA Biologics, Inc. (ADMA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
April 20, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
April 18, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
April 14, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Frequently Asked Questions
Is ADMA Biologics Inc - Common Stock publicly traded?
Yes, ADMA Biologics Inc - Common Stock is publicly traded.
What exchange does ADMA Biologics Inc - Common Stock trade on?
ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ADMA Biologics Inc - Common Stock?
The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
What is the current price of ADMA Biologics Inc - Common Stock?
The current price of ADMA Biologics Inc - Common Stock is 7.920
When was ADMA Biologics Inc - Common Stock last traded?
The last trade of ADMA Biologics Inc - Common Stock was at 05/27/26 04:00 PM ET
What is the market capitalization of ADMA Biologics Inc - Common Stock?
The market capitalization of ADMA Biologics Inc - Common Stock is 1.56B
How many shares of ADMA Biologics Inc - Common Stock are outstanding?
ADMA Biologics Inc - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
